Fmr LLC Sells 43,044 Shares of National Health Investors, Inc. (NYSE:NHI)

Fmr LLC cut its stake in National Health Investors, Inc. (NYSE:NHIFree Report) by 94.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,653 shares of the real estate investment trust’s stock after selling 43,044 shares during the quarter. Fmr LLC’s holdings in National Health Investors were worth $223,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Quantbot Technologies LP bought a new position in National Health Investors during the 3rd quarter worth approximately $323,000. Loomis Sayles & Co. L P acquired a new position in shares of National Health Investors in the 3rd quarter valued at $38,000. Daiwa Securities Group Inc. grew its holdings in shares of National Health Investors by 7.6% in the 3rd quarter. Daiwa Securities Group Inc. now owns 14,515 shares of the real estate investment trust’s stock valued at $1,220,000 after buying an additional 1,027 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of National Health Investors by 17.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock valued at $71,651,000 after buying an additional 123,596 shares during the period. Finally, Landscape Capital Management L.L.C. acquired a new stake in National Health Investors during the 3rd quarter worth $251,000. 62.51% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on NHI. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Truist Financial lifted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Finally, Bank of America began coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $76.33.

Check Out Our Latest Stock Analysis on NHI

National Health Investors Price Performance

NYSE NHI opened at $69.85 on Friday. The firm’s 50 day moving average is $76.02 and its 200-day moving average is $75.54. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $3.17 billion, a PE ratio of 24.00, a price-to-earnings-growth ratio of 4.86 and a beta of 1.04. National Health Investors, Inc. has a 12-month low of $51.59 and a 12-month high of $86.13.

National Health Investors (NYSE:NHIGet Free Report) last released its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same period last year, the business posted $1.08 EPS. The firm’s revenue for the quarter was up 1.7% on a year-over-year basis. Equities research analysts anticipate that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 5.15%. National Health Investors’s dividend payout ratio (DPR) is presently 123.71%.

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Stories

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.